Maria Sejersten Ripa

607 total citations · 1 hit paper
18 papers, 338 citations indexed

About

Maria Sejersten Ripa is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Maria Sejersten Ripa has authored 18 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Maria Sejersten Ripa's work include Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Maria Sejersten Ripa is often cited by papers focused on Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Maria Sejersten Ripa collaborates with scholars based in Denmark, United States and Germany. Maria Sejersten Ripa's co-authors include John B. Buse, Søren Rasmussen, Johannes F.E. Mann, Silvio E. Inzucchi, Sharon L. Mulvagh, John Deanfield, G. Kees Hovingh, Darren K. McGuire, Lawrence A. Leiter and Rodica Pop‐Busui and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Stroke.

In The Last Decade

Maria Sejersten Ripa

18 papers receiving 332 citations

Hit Papers

Oral Semaglutide and Cardiovascular Outcomes in High-Risk... 2025 2026 2025 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
    2025 89 citations Darren K. McGuire, Nikolaus Marx et al. New England Journal of Medicine profile →

Peers

Maria Sejersten Ripa
Rishi Patel United States
Tea Monk Fries Denmark
Imma Forzano Italy
C. Erick Kaufman United States
M. Rehman France
Hans-Ulrich Haering Germany
Richard E. Pratley United States
Shih‐Chen Tung Taiwan
Luigi Sposato Australia
Rishi Patel United States
Maria Sejersten Ripa
Citations per year, relative to Maria Sejersten Ripa Maria Sejersten Ripa (= 1×) peers Rishi Patel

Countries citing papers authored by Maria Sejersten Ripa

Since Specialization
Citations

This map shows the geographic impact of Maria Sejersten Ripa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Sejersten Ripa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Sejersten Ripa more than expected).

Fields of papers citing papers by Maria Sejersten Ripa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Sejersten Ripa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Sejersten Ripa. The network helps show where Maria Sejersten Ripa may publish in the future.

Co-authorship network of co-authors of Maria Sejersten Ripa

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Sejersten Ripa. A scholar is included among the top collaborators of Maria Sejersten Ripa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Sejersten Ripa. Maria Sejersten Ripa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
McGuire, Darren K., Nikolaus Marx, Sharon L. Mulvagh, et al.. (2025). Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes. New England Journal of Medicine. 392(20). 2001–2012. 89 indexed citations breakdown →
2.
3.
Strain, W. David, Martin James, Lawrence A. Leiter, et al.. (2022). Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6. Stroke. 53(9). 2749–2757. 49 indexed citations
4.
Verma, Subodh, Mohammed Al‐Omran, Lawrence A. Leiter, et al.. (2022). Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease. Diabetes Obesity and Metabolism. 24(7). 1288–1299. 29 indexed citations
5.
Verma, Subodh, Udi Fainberg, Mansoor Husain, et al.. (2021). Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide. Diabetes Obesity and Metabolism. 23(7). 1677–1680. 4 indexed citations
6.
7.
Verma, Subodh, Udi Fainberg, Mansoor Husain, et al.. (2020). APPLYING REWIND CVD CRITERIA TO SUSTAIN 6 AND PIONEER 6: AN EXPLORATORY ANALYSIS OF CV OUTCOMES WITH SEMAGLUTIDE. Journal of the American College of Cardiology. 75(11). 1922–1922. 1 indexed citations
8.
9.
Verma, Subodh, Stephen C. Bain, Johannes F.E. Mann, et al.. (2020). Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials. Diabetes Obesity and Metabolism. 22(11). 2193–2198. 16 indexed citations
10.
Leiter, Lawrence A., Stephen C. Bain, Deepak L. Bhatt, et al.. (2020). The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials. Diabetes Obesity and Metabolism. 22(9). 1690–1695. 23 indexed citations
11.
Weeke, Peter, Lia E. Bang, Dan Eik Høfsten, et al.. (2019). Clinical characteristics and lipid lowering treatment of patients initiated on proprotein convertase subtilisin-kexin type 9 inhibitors: a nationwide cohort study. BMJ Open. 9(4). e022702–e022702. 4 indexed citations
12.
13.
Jia, Xiaoming, Einar Heiberg, Maria Sejersten Ripa, et al.. (2018). Correlation of ST changes in leads V4–V6 to area of ischemia by CMR in inferior STEMI. Scandinavian Cardiovascular Journal. 52(4). 189–195. 1 indexed citations
14.
Engblom, Henrik, Einar Heiberg, Marcus Carlsson, et al.. (2018). The significance of ST‐elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging. Annals of Noninvasive Electrocardiology. 23(6). e12580–e12580. 4 indexed citations
15.
Engblom, Henrik, Einar Heiberg, Marcus Carlsson, et al.. (2018). Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging. Journal of Electrocardiology. 51(4). 563–568. 5 indexed citations
16.
Ripa, Maria Sejersten. (2012). The ECG as decision support in STEMI.. PubMed. 59(3). B4413–B4413. 5 indexed citations
17.
Sillesen, Martin, Maria Sejersten Ripa, S. Strange, et al.. (2006). [Telemedicine in the transmission of prehospitalisation ECGs of patients with suspected acute myocardial infarction].. PubMed. 168(11). 1133–6. 12 indexed citations
18.
Clemmensen, Peter, et al.. (2004). Prehospital diversion to hospital with acute PCI set-up using wireless 12-lead ECG transmission. Journal of Electrocardiology. 37. 222–222. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rishi Patel Breakdown of academic impact, for papers by Tea Monk Fries Breakdown of academic impact, for papers by Imma Forzano Breakdown of academic impact, for papers by C. Erick Kaufman Breakdown of academic impact, for papers by M. Rehman Breakdown of academic impact, for papers by Hans-Ulrich Haering Breakdown of academic impact, for papers by Richard E. Pratley Breakdown of academic impact, for papers by Shih‐Chen Tung Breakdown of academic impact, for papers by Luigi Sposato
Rankless by CCL
2026